Bioengineering of a Full-Thickness Skin Equivalent in a 96-Well Insert Format for Substance Permeation Studies and Organ-On-A-Chip Applications by Schimek, Katharina et al.
bioengineering
Article
Bioengineering of a Full-Thickness Skin Equivalent
in a 96-Well Insert Format for Substance Permeation
Studies and Organ-On-A-Chip Applications
Katharina Schimek 1,2,†, Hao-Hsiang Hsu 3,†, Moritz Boehme 3, Jacob Jan Kornet 3, Uwe Marx 1,
Roland Lauster 2, Ralf Pörtner 3,* and Gerd Lindner 2
1 TissUse GmbH, D-13347 Berlin, Germany; katharina.schimek@tissuse.com (K.S.);
uwe.marx@tissuse.com (U.M.)
2 Institute of Biotechnology, Department Medical Biotechnology, Technische Universität Berlin,
D-13355 Berlin, Germany; roland.lauster@tu-berlin.de (R.L.); gerd.lindner@tu-berlin.de (G.L.)
3 Institute of Bioprocess and Biosystem Engineering, Hamburg University of Technology, D-21073 Hamburg,
Germany; hao.hsu@tuhh.de (H.-H.H.); moritz.boehme@tuhh.de (M.B.); jacob.kornet@tuhh.de (J.J.K.)
* Correspondence: poertner@tuhh.de; Tel.: +49-(0)40-42878-2886
† These authors contributed equally to this work.
Received: 4 May 2018; Accepted: 1 June 2018; Published: 7 June 2018


Abstract: The human skin is involved in protecting the inner body from constant exposure to outer
environmental stimuli. There is an evident need to screen for toxicity and the efficacy of drugs and
cosmetics applied to the skin. To date, animal studies are still the standard method for substance
testing, although they are currently controversially discussed Therefore, the multi-organ chip is an
attractive alternative to replace animal testing. The two-organ chip is designed to hold 96-well cell
culture inserts (CCIs). Small-sized skin equivalents are needed for this. In this study, full-thickness
skin equivalents (ftSEs) were generated successfully inside 96-well CCIs. These skin equivalents
developed with in vivo-like histological architecture, with normal differentiation marker expressions
and proliferation rates. The 96-well CCI-based ftSEs were successfully integrated into the two-organ
chip. The permeation of fluorescein sodium salt through the ftSEs was monitored during the culture.
The results show a decreasing value for the permeation over time, which seems a promising method to
track the development of the ftSEs. Additionally, the permeation was implemented in a computational
fluid dynamics simulation, as a tool to predict results in long-term experiments. The advantage of
these ftSEs is the reduced need for cells and substances, which makes them more suitable for high
throughput assays.
Keywords: full thickness skin equivalents; multi-organ chip; substance permeation; 96-well cell
culture insert
1. Introduction
The skin, the largest human organ, offers important functions. It protects the body against
mechanical influences, ultraviolet light, temperature, and dehydration. In addition, the skin has
sensor functions responding to touch, temperature, and pain. Apart from other biochemical and
physiological functions, the skin serves as a physical barrier between the human body and the
surrounding environment [1]. Understanding this barrier’s function and its reactions to topically
applied substances is fundamental for cosmetic and pharmacological applications. Consequently,
the need to screen for the toxicity and efficacy of the skin is evident. Historically, a huge number
of animal trials have been performed worldwide to address this purpose. Tests on skin irritation,
for example, have been carried out using the Draize skin irritation test in rabbits, according to OECD
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TG 404 (Organization for Economic Co-operation and Development) [2]. However, there are several
differences between animal and human data, for example, leading to the misclassification of chemicals
using in-vivo rabbit data [3,4]. In addition, the EU Cosmetics Regulation No. 1223/2009 came into
law in 2013, and prohibits the testing of cosmetic products on animals. This increases the demand for
alternative methods [5,6]. Nowadays, human skin equivalents are widely used for animal-free tests
in drug development, the chemical and cosmetics industries, and for research purposes. There are
currently several skin equivalents commercially available: for example, EpiSkin™ (L’oreal, Clichy,
France); EpiDerm™ SIT (MatTek Corporation, Ashland, MA, USA); SkinEthik™ RHE (SkinEthic
laboratories, Lyon, France); EpiCS® (CellSystems, Troisdorf, Germany); and LabCyte EPI-MODELS24
SIT (Japan Tissue Engineering Co., Tokyo, Japan). These models are all based on only one cell type
mimicking the epidermis. However, full-thickness skin equivalents (ftSEs) with an additional dermal
layer are also available on the market (e.g., GraftSkin®, EpiDermFT®, and Phenion®). These models
are already commonly used for substance absorption tests, in order to understand the toxicity and
efficacy of pharmaceutical and cosmetic products applied to the skin [5,7,8]. The Franz diffusion cell
system is a method very widely used to determine the absorption or permeation of a substance into
the skin [9,10].
A further trend for alternatives to animal substance testing, which does not focus solely on the
skin, is the organ-on-a-chip system. The basic idea behind this approach is to emulate the smallest
physiological unit of an organ on a chip. Thus, microenvironments must be created that correspond
to the organs’ natural space. The influence of substrate topography, fluidic shear stress, and culture
perfusion are important factors in organ cultivation in the chip format [11,12]. Reproducing diseases on
the chip to test the effectiveness of active substances is of great interest to the pharmaceutical industry.
Therefore, long-term cultivation also plays an important role [13]. The variety of organ-on-a-chip-based
systems is enormous. Various microfluidic perfusion culture systems have been developed on a
research basis, and commercialization of these platforms keeps growing (e.g., µOrgano, ChipShop,
Emulate, TissUse, Nortis, AxoSim, or Draper).
A few groups have reported skin-related cultures in chip systems [14–17]. However, looking at
commercially available skin models and organ-on-a-chip systems, it becomes apparent that there is
no ftSE produced in a 96-well cell culture insert (CCI) format. We have recently described a 96-well
CCI-based culture within the two-organ chip (2OC) of either punched skin equivalents, commercially
available in a 24-well CCI format, or native skin biopsies [18–20]. This article presents a new approach
to producing ftSEs in a 96-well CCI size, which is suitable for organ-on-a-chip systems. The ftSE
consists of primary human skin cells within a collagen–elastin matrix (Matriderm®). This matrix is
provided as cellular lyophilized sheets composed of bovine elastin and collagen types I, III, and V. It is
used most frequently in clinics as a tissue replacement, supporting the ingrowth of cells and vessels
for proper regeneration of injured skin [21].
In an already published study, a method was investigated to determine and simulate the
permeation of substances in a 96-well CCI system [22,23]. Permeation is a helpful parameter that can
describe the barrier properties of the skin. The diffusion coefficient can be determined with the help
of a simulation, using a numerical optimization method. Here, these methods are modified for use
in an organ-on-a-chip system with ftSEs for future applications. In this study, the 2OC developed
by TissUse GmbH was used [13,19,24–28]. This system, about the area of a microscope slide, enables
the cultivation of different organ types on a single chip. It consists of a polycarbonate adapter plate
supporting the connectors for 96-well Transwell® holders and the pump. Two culture compartments
in one fluid circulation unit enable cultivation of two different tissue types. The fluid channel is
made of polydimethylsiloxane (PDMS), and connects the two culture compartments supplying the
organ models with nutrient solution. A micro-pump system, inspired by the human cardiovascular
system [29], is operated with compressed air and enables the fluid flow. The 2OC links metabolic
interaction of different organ types, thereby mimicking a part of the human body. This approach is
well-established for the co-culture of human liver and skin tissue [19,20,26,30]. One promising aspect
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for the future application of the 2OC is dermal in-vitro substance testing, in combination with other
tissues (e.g., liver, kidney, heart).
2. Materials and Methods
2.1. Cell Isolation and Culture
Normal human keratinocytes (NHKs) and human dermal fibroblasts (HDFs) were isolated from
prepuce biopsies (EA2/091/12 of the Ethic Committee Charité University Medicine and Eth-10/15
of the Berlin Chamber of Physicians, Berlin, Germany). The prepuce was cleaned in 80% ethanol for
30 s and rinsed with phosphate-buffered saline (PBS) prior to isolation. The subcutaneous tissue was
removed and incubated in 5 mg/mL dispase II solution (Sigma-Aldrich, St. Louis, MO, USA) at 4 ◦C
for 15–18 h to separate the thin epidermal layer from the dermis.
For the isolation of NHK, the epidermis of the biopsy was cut into small pieces and incubated in
trypsin/ethylenediaminetetracetic acid (EDTA) (Corning, Amsterdam, The Netherlands) for 15 min
at 37 ◦C. The suspension was then passed through a 70 µm nylon filter (BD Falcon™ Cell Strainer,
Erembodegem, Belgium) and centrifuged for 5 min at 300× g. The supernatant was aspirated and
the pellet re-suspended in 1 mL EpiLife medium + 1% human keratinocyte growth supplement
(HKGS) (Gibco/Life Technologies, Darmstadt, Germany), with 1% Penicillin/Streptomycin (Corning,
Amsterdam, The Netherlands) (E1 medium). Cells were seeded at a density of 1.3 × 104 cells/cm2
into collagen I-coated (Biochrom GmbH, Berlin, Germany) flasks with E1 medium. The medium was
changed twice a week. After a few days of culture, when cells reached 80% confluence, the NHKs
and melanocytes were separated by differential trypsination. Trypsin/EDTA was added in the
flask and incubated for 4–5 min at 37 ◦C to remove the melanocytes. In a second trypsination
step, with an incubation time of 10–15 min, the NHKs were passaged into new collagen-coated
flasks. The NHKs were then harvested at 80% confluency, frozen in fetal calf serum (FCS) (Corning,
Amsterdam, The Netherlands) with 10% dimethyl sulfoxide (DMSO) (Carl Roth, Karlsruhe, Germany),
and stored in liquid nitrogen until use.
For the isolation of HDFs, the dermis of the prepuce biopsy was cut into strips and incubated for
45 min in Dulbeccos’s Modified Eagle Medium (DMEM) (Corning, Amsterdam, The Netherlands),
containing 4 mg/mL collagenase NB 4 (Serva Electrophoresis GmbH, Heidelberg, Germany).
The suspension was then passed through a 70 µm nylon filter, centrifuged for 5 min at 300× g,
and the pellet was re-suspended in a 1 mL medium composed of DMEM, including glutamine,
high glucose (Corning, Amsterdam, The Netherlands) with 1% Penicillin/Streptomycin, and 10%
FCS (D10). Cells were seeded at 2 × 104 cells/cm2 and passaged once after reaching 80% confluence.
The medium was changed one day after seeding, and then every three to four days. When the HDF
reached 80% confluence again, the cells were harvested, frozen in FCS with 10% DMSO, and stored in
liquid nitrogen until used.
2.2. Manufacturing of Full Thickness Skin Equivalents
1 mm thick Matriderm® (asclepiosMedizintechnik, Gutach, Germany) pieces 4.5 mm in diameter
were punched out and degassed in PBS (Biochrom GmbH, Berlin, Germarny) within an exsiccator
(Nalgene®, Rochester, NY, USA) (see Figure 1a,b). The Matriderm® punches were transferred into a
96-well, ultra-low attachment plate (Corning, Amsterdam, The Netherlands) and 200 µL D10 medium
supplemented with 50 µg/mL L-ascorbic-2-phosphate (AAP) (Sigma-Aldrich, St. Louis, MO, USA,
D10-A) was added. The HDFs were harvested and a cell concentration of 0.4 × 105 cells/50 µL
was adjusted. The medium was removed from the Matriderm® punches, and 50 µL of the cell
suspension was injected into the punches (see Figure 1c). After 15 min incubation at 37 ◦C 150 µL,
D10-A medium was added to the wells. The dermal equivalents (DEs) were cultivated in an incubator
with a temperature of 37 ◦C and a CO2 concentration of 5% for 8–11 days, whereby the medium was
exchanged three times a week (200 µL D10-A for each well).
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seeded onto the top of the equivalent. (g) On day 20, the equivalents are lifted to the air-liquid 
interface and cultivated further for ~10 days. 
One day before seeding the keratinocytes, the DEs were sealed to the cell culture insert by the 
addition of a fibrin gel solution (see Figure 1e). Fibrinogen is immediately polymerized to fibrin if 
thrombin is added. Therefore, two solutions were prepared and transferred to 500 μL reaction tubes. 
A quantity of 10 μL per DE of fibrinogen solution (composed of 8 μL HDF (0.4 × 105 cells/8 μL) 
solution, 1 μL D10, and 1 μL fibrinogen (100 mg/mL, Baxter, Vienna, Austria)) and 10 μL thrombin 
solution (composed of 8 μL CaCl2 (40 mM in H2O; Sigma-Aldrich, St. Louis, MO, USA) and 2 μL 
thrombin (4 U/mL; Baxter, Vienna, Austria)) was needed. The medium on top and below the DE was 
removed, and 10 μL thrombin solution was mixed with 10 μL fibrinogen solution. The mixture was 
. . t t
e assed in an exsic ator. (c) Then the matrix is seed with human dermal fibro lasts. (d) On
day nine, the ftSE is transferr d into a cell culture insert system. (e) After fo r i ,
skin equivalent is ealed with a fibrin gel. (f) One day later, normal human ker tinocytes are s eded
onto the top of the equival nt. (g) On day 20, the equivalents are lifted o th a r-liquid interface an
cultiv t d further for ~10 days.
In the next step, the DEs were transferred into cell culture inserts (Transwells®, polycarbonate
membrane, 0.4 µm pore size from Corning, Amsterdam, The Netherlands) (see Figure 1d); these were
set in a customized polycarbonate holder and placed on a 48-well plate (Corning, Amsterdam,
The Netherlands) (see Figure 2). Then, 800 µL D10-A medium was added into the bottom of the
well and 75 µL into the cell culture insert on top of the DEs. While a standard 96-well receiver plate is
normally used for the culture of reconstructed human epidermis models, ftSEs require a larger volume
of medium per square centimeter culture area. Therefore, the described customized polycarbonate
holder was developed. The DEs were cultivated further for 3–6 days, and the D10-A medium was
changed three times a week.
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Figure 2. Pictures of the 48-well plate Transwell® holder. (a) The Transwell® can fitted in the
polycarbonate (PC) holder plate and (b) positioned in a 48-well plate.
One day before seeding the keratinocytes, the DEs were sealed to the cell culture insert by the
addition of a fibrin gel solution (see Figure 1e). Fibrinogen is immediately polymerized to fibrin if
thrombin is added. Therefore, two solutions were prepared and transferred to 500 µL reaction tubes.
A quantity of 10 µL per DE of fibrinogen solution (composed of 8 µL HDF (0.4 × 105 cells/8 µL)
solution, 1 µL D10, and 1 µL fibrinogen (100 mg/mL, Baxter, Vienna, Austria)) and 10 µL thrombin
solution (composed of 8 µL CaCl2 (40 mM in H2O; Sigma-Aldrich, St. Louis, MO, USA) and 2 µL
thrombin (4 U/mL; Baxter, Vienna, Austria)) was needed. The medium on top and below the DE
was removed, and 10 µL thrombin solution was mixed with 10 µL fibrinogen solution. The mixture
was transferred immediately to the DEs. The clot was incubated for 30–60 min at 37 ◦C in the
CO2-incubator for polymerization. The dermis equivalents were cultured one day further in D10-A
medium, as described above.
On the next day, NHKs were harvested, and a cell concentration of 0.8 × 105 cells/50 µL was
adjusted with the E1 medium supplemented to 1.5 mM CaCl2 (E2). The medium was removed from
the ftSEs, and 50 µL of the cell suspension was added on top (see Figure 1f). After incubating for 2 h at
37 ◦C, 15 µL of the E2 medium were added into the top well and 900 µL into the bottom well below the
ftSE. After seven days of submerged cultivation (medium changed three times a week) the medium
was removed, and the ftSEs were further cultivated in an air lift (ALI) for 10 days (see Figure 1g).
For the ALI cultivation, the E3 medium, composed of the E2 medium supplemented with 50 µg/mL
AAP and 5 ng/mL keratinocyte growth factor (Sigma-Aldrich, St. Louis, MO, USA), was used (800 µL
medium, in the bottom well only), and the medium was changed three times a week.
2.3. Cultivation in Two-Organ Chip
One part of the ftSEs were cultivated further in a 2OC, produced and provided by TissUse GmbH
(Berlin, Germany) (see Figure 3). Further information about the 2OC can be found in Wanger et al. [20],
Materne et al. [19], and Schimek et al. [25]. Prior to cultivation, the 2OC was flushed with an E3
medium. The culture compartments of the chip were both filled with 300 µL of the E3 medium. Prior to
integration into the chip, the Transwell® containing the ftSE was cut off below the bracket with a heated
scalpel and removed. The Transwells® were then positioned air bubble-free into the Transwell®-holder,
which was screwed into one of the 2OC compartments. The other compartment of each circuit of a
2OC was used as a media reservoir, and was filled up with 600 µL of the E3 medium. The 2OCs were
connected to the TissUse Control Units, adjusted to a pump rate of 2 Hz, and incubated at 37 ◦C and
5% CO2. The medium was changed every second day.
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2.4. Staining
At the end of the culture, the tissues were harvested and frozen in cryomedium TissueTek (Sakura
Finetek Germany GmbH, Staufen, Germany) and cut with a Cryotome in slices with a thickness of
8 µm. For the immunofluorescence staining the skin slices were fixed in acetone (Carl Roth, Karlsruhe,
Germany) at −20 ◦C for 10 min, washed with PBS and blocked with 10% goat serum (Sigma-Aldrich,
St. Louis, MO, USA) in PBS for 20 min. Tissues were then incubated with the primary antibody
over night at 4 ◦C and washed with PBS. Subsequently, the conjugated secondary antibody and
4,6-diamidine-2-phenylindole (DAPI) (Sigma-Aldrich, St. Louis, MO, USA) (1:2000 diluted in PBS)
were added and incubated for 45 min. The sections were washed twice in PBS, covered with mounting
medium and stored at −20 ◦C in the dark until imaging. The antibodies are listed on Table 1.
Table 1. List of antibodies used for immunofluorescence staining.
Antibodies Dilution in PBS Manufacturer
Collagen I, mouse anti-human, 5.9 mg/mL 1:100 Sigma 1
Cytokeratin 10, mouse anti-human, 1 mg/mL 1:100 Chemicon 2
Cytokeratin 15, rabbit anti-human, 100 µg/mL 1:100 Chemicon 2
Filaggrin, mouse anti-human, 0.2 mg/mL 1:50 Thermo Fisher 3
IgG–CF 488, goat anti-rabbit, 2 mg/mL 1:200 Biotium 4
IgG–CF 594, goat anti-mouse, 2 mg/mL 1:200 Biotium 4
Vimentin, IgG rabbit anti-human, 200 µg/mL 1:100 Santa Cruz 5
1 Sigma-Aldrich, St. Louis, MO, USA. 2 Merck, Darmstadt, Germany. 3 Thermo Fisher, Schwerte, Germany. 4
Biotium, Fremont, CA, USA. 5 Santa Cruz Biotechnology, Dallas, TX, USA.
For the hematoxylin and eosin (HE) staining, the slides were fixed in acetone for 10 min at −20 ◦C
and then washed in distilled water. The slides were then stained in haematoxylin-solution (Harris,
VWR, Radnor, PA, USA) for 5 min, and washed again in distilled water. The slices were differentiated
by two quick dips in 0.3% acid alcohol. The staining turned blue when tap water was run over the
slides for 5 min. Staining in eosin (Merk, Darmstadt, Germany) followed for 2 min, after which the
slides were washed again in tap water and then dehydrated in alcohol solutions with increasing
concentration (70, 96, and 99% and Roti®-Histol (Carl Roth, Karlsruhe, Germany)) for 5 min each.
The stained slides were covered with Roti-Histokitt (Carl Roth, Karlsruhe, Germany), and a cover slip
was attached.
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2.5. Permeation Measurement
The permeation experiments were performed in 2OCs. The fluid channels of the chips were
filled with E2 medium, and the ftSEs were transferred in the 2OC as described before (see Figure 4).
The medium reservoir compartment was used for the acceptor, and was filled with 300 µL E2 medium.
Fluorescein sodium salt (Carl Roth, Karlsruhe, Germany) with a concentration of 0.1 mg/mL in E2
medium was used as donator substance, and 75 µL of donator substances were applied onto the top of
the ftSE in the CCI. The acceptor (receiver plate, bottom of the ftSE) was filled with 300 µL E2 medium
(see Figure 4). During the experiment, the 2OC was positioned in the incubator at 37 ◦C and 5% CO2.
Hourly, 100 µL samples were taken from the acceptor and transferred to a 96-well plate to measure the
fluorescence. After the measurement, the sample was returned into the 2OC.
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1. The 96-well CCI system with ftSE is positioned on Ins rt 2. The donator is the investigated substance
on the ftSE. Black arrows indicate the dire tion of the fluid flow, and the red arrows the permeation.
To determine the permeation coefficient, the following equation derived from Fick’s first law
was used:
dcA
dt
= P × A cD
VA
, (1)
where cA is the concentration of the substance at the acceptor, cD is the concentration at the donator,
t is time, P is the permeation coefficient, A is the permeation surface, and VA is the volume of the
acceptor. This equation can only be applied when cA  cD.
2.6. Numerical Simulation
The numerical simulation was executed with the program COMSOL Multiphysics (Version 5.1,
COMSOL Inc., Stockholm, Sweden) under the following assumptions:
(a) The diffusion coefficient of fluorescein sodium salt in H2O was set to a value of 1 × 10−9 m2/s,
which is approximately 100× higher than the diffusion coefficient through the ftSE.
(b) In the experiment, the substance diffuses through the ftSE, and a membrane of the CCI system.
This is considered to be one homogenous phase.
(c) For the computation fluid dynamic (CFD) simulation, all physical boundary effects on walls
were neglected.
(d) The fluid flow in the 2OC was assu ed to be a laminar. The experi entally easured ean
value was used as flow velocity.
The fluid channel geo etry of the 2OC was implemented in the simulation. On the position
of Insert 1, a cylinder was generated with the acceptor volume. The donator and ftSE volume were
also realized as a cylinder, and located at the Insert 2 position (see Figure 5). T o s all cuboids ere
positioned on the icro pu p for the in- and outflo of the fluid si ulation (see Figure 5, zoo ed
picture). There is a gap bet een the cuboids that as not traversable for the flow. The volu es
correspond to the real experi ental setup.
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Figure 5. Geometry of the numerical simulation. The green cylinder shows the volume of the acceptor,
and the blue cylinder shows the volume of the donator. At the bottom of the acceptor the ftSE is located.
The zoom shows the position of the in- and outflow for the fluid simulation.
For the fluid flow simulation, the “laminar flow” module was used. All areas affected by the fluid
flow were included in the CFD (exceptions are the donator, the ftSE, and the gap). The material in this
area was declared as water. The position of the in- and outflow of the fluid were defined on the two
small cuboids, mentioned above. The velocity was set at a value of 15.76 mm/s. A stationary study
with a GMRES (generalized minimal residual method) solver was used to simulate the laminar flow.
The integrated auto mash was used to generate the grid, and the element size “normal” was selected
(see Figure 6).
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Figure 6. The mash of the numerical simulation. To generate the grit, the auto mash function with
“normal” tetrahedral element size was used.
The diffusion process of fluorescein sodium salt was simulated with the “transport of diluted
species” module. All areas except for the ftSE were assigned a diffusion value of 1 × 10−9 m2/s.
The diffusion coefficient of the ftSE was assigned a value (calculated from the parameter adaption).
All areas circulated by the liquid have been coupled to the CFD. A time-dependent study with a
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nonlinear Newton’s method was used to simulate the diffusion process. The time range was set from
0 s to 20,000 s, with a time step of 100 s.
The diffusion coefficient of the ftSE was determined with the “optimization” module. For this,
the experimental data were integrated in the “global last-square objective”. The first column of the
data was defined as the time, and the second column expresses the concentration of the donator.
The concentration of the donator was set as the average concentration of the cylinder on Insert 1,
and the “global control variable” was set with an initial value of 1 and a control range between
0–1000. For the parameter adaption, the global control variable was multiplied by the factor 1 × 10−10.
The diffusion coefficient of ftSEs was set as the chosen global control variable, in order to optimize
the value at this area. The study of this module was implemented in the time-dependent study of the
“transport od diluted species”, and the SNOPT (Spares Nonlinear Optimizer) method with tolerance
of 1 × 10−8 was chosen. Exact step-by-step instructions for the simulation on an CCI system with the
similar simulation modules can be found in Hsu et al. [22].
3. Results
3.1. Histological Analysis of the Full-Thickness Skin Equivalents
The cutaneous tissue morphology and expression pattern of several differentiation markers have
been analyzed, using histological and immunohistochemical staining at different time points over a
culture period of 24 days in the ALI, in order to characterize ftSEs over a long-term culture period.
Histological staining shows that HDFs are distributed homogeneously throughout the dermis matrix
after 14 days pre-culture (Figure 7a,g). A thin layer of fibrin glue sealed the gap between the colonized
matrix and the CCI wall. As a result, an accumulation of fibroblasts formed at the upper part of
the dermal equivalent (Figure 7b,h). Several epidermal layers were already apparent after seven
days of ALI cultivation (Figure 7c,i). An increase in the number of layers was visible until day 10.
Furthermore, a thicker stratum corneum and an epithelium containing more keratohyalin granules in
the stratum granulosum emphasized the advanced differentiation process (Figure 7d,j). No differences
between 10 and 17 days of ALI culture could be recognized, except for further thickening of the stratum
corneum (Figure 7e,k). After 24 days, all layers were still present, but seemed to be more compact
(Figure 7f,l). Keratinocytes of the basal layer were regularly arranged with a columnar structure
throughout the cultivation period (Figure 7i–l).
Immunofluorescence analysis should provide an insight into the expression kinetics of the skin
equivalents. Differentiation-specific keratin expression patterns are shown here by K10/K15 double
staining (Figure 8a,e,i,m,q,u). Without any keratinocytes seeded on top of the dermis, no K10/K15
expression was observed (Figure 8a,e). At all other time points, a strict border between K15-positive
basal keratinocytes and K10-positive suprabasal cells was visible (Figure 8i,m,q,u).
Filaggrin protein expression was seen during the epidermal differentiation process. This late
differentiation marker is expressed and processed by cells in the stratum granulosum. Filaggrin
expression in skin equivalents increased significantly over time (Figure 8c,g,k,o,s,w). While barely
visible until seven days of air-lift culture, intense staining was seen after 17 and 24 days of culture,
indicating advanced differentiation levels.
The formation of a basal membrane was proven by a prominent collagen IV staining
(Figure 8b,f,j,n,r,v). Collagen IV expression within the dermis and basal zone, already present
after seven days of ALI culture, increased slightly over time. Deposition of collagen IV was
observed, particularly near the dermal–epidermal junction, while decreasing towards the lower
dermis (Figure 8r,v).
Vimentin was used as a marker for fibroblasts populating the dermis, which were found
to be spread throughout the entire construct (Figure 8d,h,l,p,t,x). An increased number of cells
accumulated within the upper part of the dermis construct. This trend continued further when
keratinocytes were added on top of the dermis, resulting in a densely-populated upper dermis and a
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less-densely-populated lower dermis. This phenomenon can also be observed within the papillary
and reticular dermis of native human skin in vivo.
The vitality of the skin equivalents after long-term culture was determined by TUNEL-Ki67
immuno-labelling (Figure 9). The mitotic activity of the keratinocytes, visualized by Ki67 staining,
showed a still-considerable number of proliferating keratinocytes within the basal layer after 24 days
of air-lift culture. Concurrently, only a few apoptotic TUNEL-positive cells were seen within the
ftSE, indicating a still viable skin equivalent. The long-term maintenance and regular differentiation
characteristics suggested a balance between proliferation, differentiation, and apoptosis, leading to a
physiological tissue homeostasis.Bioengineering 2018, 5, x FOR PEER REVIEW  10 of 19 
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Figure 7. e atoxylin and eosin ( E) staining of full-thickness skin equivalents (ftSEs). The ftSE
orphology as evaluated at different time points. Images show representative cuts of ftSEs of
(a,g) dermis only, (b,h) dermis with fibrin gel added on top, and (c,i) after seven days, (d,j) 10 days,
(e,k) 17 days, and (f,l) 24 days of ALI culture. The skin equivalents developed a multilayered an
stratified epithelium during this 24- ay period. (a–f) Scale bar: 500 µm. (g–l) Scale bar: 50 µm.
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3.2. Multi-Organ-Chip Culture
Subsequently, the ftSEs were cultured for seven days in the 2OC to make them suitable for future
co-culturing experiments with other organ equivalents.
Histological analysis of ftSEs cultivated in the 2OC showed a comparable morphology of ftSEs
cultured at static conditions (Figure 10a,b).
Immunohistochemical analysis demonstrates the expression of early differentiation markers
(Figure 10d) and the presence of a basement membrane (Figure 10e). The late differentiation marker
filaggrin, however, is expressed only weakly (Figure 10f). The high expression of vimentin (Figure 10g)
and collagen IV (Figure 10e) within the dermal matrix may reflect a higher proliferative and active
level of the residing fibroblasts. The skin equivalents remained viable and proliferative, as indicated
by TUNEL/Ki67 staining (Figure 10c).
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As skin integrity is important for substance permeation tests, the skin equivalents were 
evaluated macroscopically as well as by measuring the trans-epithelial electrical resistance (TEER) 
(Figure 11i) and permeation (Figure 12) during the entire cultivation period. 
Differences in size and skin integrity could be observed macroscopically. About 40% of the skin 
equivalents prepared within each experiment failed due to severe shrinkage, overfloating, or other 
reasons. However, most of the skin equivalents remained stable until the end of the culture. The 
differences visible macroscopically were confirmed by differing TEER. While skin equivalents with 
high TEER showed a homogeneous epidermis until the CCI wall (Figure 11a–c), overfloating medium 
at the edges and the epidermis restricted to the center of the CCI were noticed for skin equivalents 
with low TEER (Figure 11e–g). This observation could be verified by HE staining (Figure 11d,h). 
Fewer epidermal layers could have also caused low TEER (Figure 11j,k). 
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s skin integrity is important for substance permeation tests, the skin equivalents were evaluated
macroscopically as well as by measuring the trans-epithelial electrical resistance (TEER) (Figure 11i)
and permeation (Figure 12) during the entire cultivation period.
ifferences in size and skin integrity could be observed macroscopically. About 40% of the
skin equivalents prepared within each experiment failed due to severe shrinkage, overfloating,
or other reasons. However, most of the skin equivalents remained stable until the end of the culture.
The differences visible macroscopically were confirmed by differing TEER. While skin equivalents ith
high TEER sho ed a ho ogeneous epider is until the I all (Figure 11a–c), overfloating ediu
at the edges and the epider is restricted to the center of the I ere noticed for skin equivalents
ith lo TEER (Figure 11e–g). This observation could be verified by HE staining (Figure 11d,h). Fewer
epidermal layers could have also caused low TEER (Figure 11j,k).
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A diffusion coefficient of 20.45 × 10−11 m2/s was calculated for the ftSEs in the pre-culture. This 
value decreased to a value of 4.41 × 10−11 m2/s on day 0 (day of the ALI). After one week of cultivation, 
the diffusion coefficient was 2.55 × 10−11 m2/s, and increased to a value of 2.88 × 10−11 m2/s on day 10. 
The diffusion coefficient decreased further to a value of 1.65 × 10−11 m2/s on day 24 (Table 3). Similar to 
the permeation experiment, inversely proportional behavior was seen for the ftSEs. Validation of the 
simulation with the experimental data was achieved by calculating the coefficient of determination 
(r²) (Table 3). The values for the different time points are listed in Table 3. The value was highest on 
day 24, declining with decreasing cultivation time and reaching a value of 0.34 on day 0. The value 
even fell below zero for the pre-culture. This indicates that the simulation on day 24 matches the 
experimental data closely, but moves away from the experimental value as it approaches pre-culture. 
The negative value of r2 suggests that the mean value adjusts the experimental data better than the 
simulation. The relationship between the simulation and the experiment is visualized by plotting the 
data (Figure 13). The simulation shows the same course for the experiment on day 24. At day 0, the 
concentration of the experimental data increased more rapidly compared to the simulation. 
Figure 12. Permeation coefficient over the time of the ftSE. The permeation of fluorescein sodium salt
through the ftSEs was observed over time. The ALI was executed at day 0. The days before pre-culture
are declared with a minus. A continuous decrease of permeation over time can be seen (gray arrow).
Macroscopically defective skin equivalents were sorted out for the next experiment.
The permeation of fluorescein sodium salt through the ftSEs was studied to determine a correlation
with corneal differentiation. A permeation coefficient of 8.23 × 10−8 m/s was detected during the
pre-culture (5 days before ALI). The parameter decreased to a value of 6.45 × 10−8 m/s on the day of
ALI. After seven days of cultivation in ALI conditions, the coefficient was still decreasing down to a
value of 2.88× 10−8 m/s, and increased slightly to a value of 3.99 × 10−8 m/s on day 10 of ALI. As the
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experiment progressed, a permeation coefficient of 3.36 × 10−8 m/s was measured on day 17 in ALI,
and a coefficient of 2.07 × 10−8 m/s was measured at the end, after 24 days of cultivation. Overall,
a continuous decrease of the permeation coefficient of fluorescein sodium salt through the ftSEs over
the cultivation period was observed (Figure 12). This indicates a relationship between the permeation
coefficient and corneal differentiation of the ftSEs. The permeation coefficients, errors, and number of
samples are listed in Table 2.
Table 2. Result of the permeation experiments with fluorescein sodium salt through the ftSE.
The permeation at different times during the cultivation was investigated.
Time (Day in ALI) Permeation Coefficient (×10−8 m/s) Error (×10−8 m/s) Number of Samples (N)
Pre-culture 8.23 1.53 3
Day 0 6.45 2.83 4
Day 7 2.88 1.60 5
Day 10 3.99 2.46 5
Day 17 3.36 2.86 5
Day 24 2.07 1.66 5
Blank 0.03 0.02 5
3.4. Numerical Simulation
The diffusion coefficient through the ftSE into the 2OC system was evaluated by mathematical
approximation. Therefore, a numerical simulation was used to fit the diffusion coefficient with the
data from the permeation experiment, described previously.
A diffusion coefficient of 20.45 × 10−11 m2/s was calculated for the ftSEs in the pre-culture. This
value decreased to a value of 4.41× 10−11 m2/s on day 0 (day of the ALI). After one week of cultivation,
the diffusion coefficient was 2.55 × 10−11 m2/s, and increased to a value of 2.88 × 10−11 m2/s
on day 10. The diffusion coefficient decreased further to a value of 1.65 × 10−11 m2/s on day 24
(Table 3). Similar to the permeation experiment, inversely proportional behavior was seen for the ftSEs.
Validation of the simulation with the experimental data was achieved by calculating the coefficient of
determination (r2) (Table 3). The values for the different time points are listed in Table 3. The value was
highest on day 24, declining with decreasing cultivation time and reaching a value of 0.34 on day 0.
The value even fell below zero for the pre-culture. This indicates that the simulation on day 24 matches
the experimental data closely, but moves away from the experimental value as it approaches pre-culture.
The negative value of r2 suggests that the mean value adjusts the experimental data better than the
simulation. The relationship between the simulation and the experiment is visualized by plotting
the data (Figure 13). The simulation shows the same course for the experiment on day 24. At day 0,
the concentration of the experimental data increased more rapidly compared to the simulation.
Table 3. Results of the calculated diffusion coefficient with the numerical simulation and the coefficient
of determination (r2) regarding the experimental data. The diffusion of fluorescein sodium salt through
the ftSEs at different cultivation times was investigated.
Time Diffusion Coefficient (×10−11 m2/s) r2
Preculter 20.45 −19.15
Day 0 4.41 0.32
Day 7 2.55 <0.01
Day 10 2.88 0.49
Day 17 2.66 0.83
Day 24 1.65 0.98
Blank 0.03 0.02
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4. Discussion
The aim of this work was to develop an ftSE with the size of a 96-well CCI that can be used for an
organ-on-a-chip system. These skin equivalents are small, so fewer cells and less substance are needed.
Therefore, the ftSE can be used for high throughput assays.
The immunological staining showed regular epidermal development and expression of typical
marker proteins. The keratinocytes alter their keratin expression with an increasing differentiation
status. Undifferentiated, mitotically-active keratinocytes of the basal layer express the keratins
K5/K14 [31] and K15 [32]. When differentiation is initiated in the keratinocytes of the suprabasal
layers, expression of K1 and K10 is characteristic [32]. Filaggrin, a protein of the cornified envelope
used as a late differentiation marker [33], was found at later stages of ALI. The presence of this protein
indicates a regular epidermal development of the ftSEs. Physiological paracrine signaling between
keratinocytes in the epidermis and fibroblasts in the dermis is necessary for the development of the
basement membrane zone. The crosstalk triggers the synthesis of a complex network of extracellular
matrix located at the dermal–epidermal junction. The main components of the basement membrane
zone ar collagen IV, c llagen VII, perlecan, idogen, and various l minins [34]. T e expression of the
baseme t membrane protein collagen IV at the interf c of the epidermis and the ermal ma rix of th
ftSEs provides evidence for their pot ntial to organize themselves in a physiological way. Vimentin
is the major intermedi te filament prot in of mesenchymal cells, and is used widely as a marker for
dermal fibrobla ts [35]. Interestingly, mo e fibroblasts accumulated it in the upper part o the dermis.
This is close to the n ive dermal rchitecture, where the fibroblasts re dens in the upper papillary
dermis than in the lower reticular dermis [36]. This incre s number of fibr blasts could also explain
the enhanced collagen IV accumulation in the upper part of the dermis. A leak-proof connection of th
skin equiv l nt with the CCI w ll is indispen able for a controlled experiment [37]. The c mbinati n of
the Matride m® matrix with a fibrin gel to engineer the dermal c mponent of the ftSE h s been prov
to be advantageous. Th fibrin acts as a seala t, an furthermor , impr ves keratinocyt growth,
as shown in several clinical studies [38–40].
According to OECD test guide ines (e.g , No. 428), the integri y of the skin ba rier
must be evaluated before a substance can be applied for penetration/absorption studies.
Transepithelial/t sendothelial electrical resistance is widely accepted qu titative and noninvasive
m thod based on measuring ohmic resista ce [33]. As the intention of the ftSEs was to develop
skin equivalents compatible with skin p etration/absorption studies, TEER mea urements were
conducted to verify the ftSEs’ barrier int grity. The TEER ecapi ul ted the fin ings from macroscopic
and histological analyse . Shrinkage an worse epidermal performance oth resulted in low TEER
Bioengineering 2018, 5, 43 16 of 19
values. However, higher TEER was still low in comparison to the TEER desired described in literature.
The standard limit value based on experiments with punched human skin samples, for example,
was 1 kΩ. However, these values have to be regarded with care, and vary a lot between the
laboratories, as the resistance measured is dependent on the device, the frequency applied, the resulting
current, the ionic strength of the solution, and the surface area of the skin sample [41]. While TEER
measurements are commonly used for RHE characterization [42], they have not been described
as routine tools for ftSEs, due to severe shrinkage. One alternative is measuring the impedance
across a wide spectrum of frequencies [43], or the permeation measurement of a model substance,
as shown here.
Microfluidic technologies have made it possible to control the microenvironment dynamically
and allow for the crosstalk of multiple organ systems, by which more reliable drug discovery studies
can be conducted [44]. The aim of this study was, therefore, to include the established 96-well
CCI-based skin equivalents into the 2OC, as shown previously [18–20]. Skin equivalents cultured
for seven days within the 2OC remained viable, and showed a nearly consistent epidermal and
dermal structure compared to static culture. Collagen IV and vimentin expression within the dermis
increased substantially, indicating highly active fibroblasts, most likely due to the dynamic environment
constantly replenishing the medium. This is in accordance with findings in other publications
describing the culture of ftSEs in organ-on-a-chip systems. For example, EpidermFT™ skin equivalents
(MatTek corporation, Ashland, MA, USA) cultured within the 2OC showed rearrangement and
compression of the dermal matrix in dynamic cultures and a denser appearance of cell nuclei, indicating
an enhanced proliferation of the fibroblasts in dynamic compared to static cultures. However, hardly
any difference in viability between statically and dynamically cultured ftSEs was visible after nine
days of culture, although viability was slightly worse in static cultures [18]. Research published by
Abaci et al. [14] showed long-term maintenance of the dermo-epidermal ftSEs cultured on-chip that
was also similar to the static culture. Contrarily, ex-vivo skin biopsies cultured within the 2OC showed
substantial differences to the static culture, and the viability and morphology could be preserved over
14 days in a dynamic culture [18]. This indicates the need for perfused culture systems if skin models
with increased complexity are used—for example, with integrated hair, vasculature, the immune
system, or adipose tissue.
The permeation of substances was measured in a 96-well CCI system in previous experiments [22].
The permeation measurement was transferred to the 2OC system for further applications. The barrier
function of the skin is one of its main characteristics. Thus, its permeability can be used as a quality
factor to characterize the skin equivalent. It could be shown that the development of the ftSE can be
followed with the help of the permeation measurement. It must generally be claimed that the barrier
of the ftSE still differs from human skin. Permeation experiments with testosterone [8], aldosterone,
hydrocortisone [45], and corticosterone [46], which have a similar molecular size as fluorescein
sodium salt, show a permeation coefficient through human skin in the range of 0.4 × 10−10 up to
3.76 × 10−9 m/s. These are more than ten times smaller than the values measured for the ftSEs.
However, this method of permeation determination seems to be promising for assessing the condition
of the skin equivalent during the culture. This could represent a possible additional quality control for
the production of the skin equivalent.
The simulation is representative of the ftSEs at the last stage of the cultivation, where the skin
equivalent is well-differentiated. At the beginning of the culture, the deviation between the simulation
and the experiment is high. The actual diffusion process was faster than the simulation. In all
likelihood, the diffusion cannot be precisely described with Fick’s law. A possible reason for this
effect is the fluid flow of the 2OC. The accelerated distribution of the substance can cause anomalous
diffusion [47]. The simulation has to be extended with an equation for abnormal diffusion [48] to
account for this effect.
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5. Conclusions
In conclusion, skin equivalents were generated successfully inside 96-well CCIs, and their
implementation into the 2OC proved its suitability as a pharmacological test system for substance
penetration studies. Furthermore, it was possible to extend the simulation to the 2OC, and the diffusion
coefficient could be determined for differentiated ftSEs. The numerical simulation can be used further
to predict long-term effects and support and reduce experimental efforts.
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